Prognostic impact of HER2 overexpression/amplification in women with pT1a NO MO breast cancer with known screening status: Results from a multicenter populationbased cancer registry study / Musolino, A; Michiara M; Boggiani D; Sikokis A; Rimanti A; Pellegrino B; Silini EM; Campanini N; Barbieri E; Sgargi P; Falcini F; Pinto, C. - In: CANCER RESEARCH. - ISSN 0008-5472. - (2016).

Prognostic impact of HER2 overexpression/amplification in women with pT1a NO MO breast cancer with known screening status: Results from a multicenter populationbased cancer registry study

MUSOLINO A;
2016-01-01

2016
Prognostic impact of HER2 overexpression/amplification in women with pT1a NO MO breast cancer with known screening status: Results from a multicenter populationbased cancer registry study / Musolino, A; Michiara M; Boggiani D; Sikokis A; Rimanti A; Pellegrino B; Silini EM; Campanini N; Barbieri E; Sgargi P; Falcini F; Pinto, C. - In: CANCER RESEARCH. - ISSN 0008-5472. - (2016).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2874810
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact